En español

Menu

Publications

Quick Links

National Advisory Council Agenda

133rd Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Gillian Acca via email or phone at 301-827-5843 or through the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the workshop.

September 5, 2019

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

9:00 a.m. Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
9:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Kurt Rasmussen, Ph.D., Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Diversity and Health Disparities (ODHD)
Albert Avilla, Ph.D., Director

10:15 a.m. Break

Open Session

10:30 a.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
10:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:45 a.m. Discussion
Council Members
12:15 p.m. Lunch Break
1:30 p.m. NIDA AIDS Strategic Plan​
Redonna Chandler, Ph.D., Director, AIDS Research Program
2:00 p.m. Concept Clearances​
  • Avenir Award Program for Research on Substance Abuse and HIV/AIDS – Vasundhara Varthakavi, DVM, Ph.D. Associate Director, ARP
  • Implementing the HIV Service Cascade for Justice-Involved Populations – Minnjuan Flournoy Floyd, Ph.D. Health Scientist Administrator, Services Research Branch, Division of Epidemiology, Services and Prevention Research (DESPR)
  • Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Service – Minnjuan Flournoy Floyd, Ph.D. Health Scientist Administrator, Services Research Branch, Division of Epidemiology, Services and Prevention Research (DESPR)
  • Reducing Stigma Related to Drug Use in Human Service Settings – Amy Goldstein, Ph.D. Branch Chief, Prevention Research Branch, DESPR
  • Investigating the roles of biomolecular condensates (BMCs) in substance use disorders and/or HIV infection, latency, or pathogenesis – Jennifer Wenzel, Ph.D. Program Officer, Behavioral and Cognitive Neuroscience Branch, Division of Neuroscience and Behavior (DNB)
  • Using imaging approaches to characterize HIV reservoirs in lymphoid tissues & CNS in the context of injection drug use – Woody Lin, Ph.D. Health Scientist Administrator, Integrative Neuroscience Branch, DNB
  • HIV Pathology and Latency Studies Using Live Functional Behaving Human Cell Chimera Animal Brains – Da-Yu Wu, Ph.D. Health Scientist Administrator, Genetics, Epigenetics, and Developmental Neuroscience Branch, DNB
  • Using Cutting Edge Tools to Study Mechanisms of Opioid Action in Rodent Brain Circuits and Cells – Roger Little, Ph.D. Deputy Director, Division of Neuroscience and Behavior (DNB)
  • Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose – Iván Montoya, M.P.H., M.D. Deputy Director, Division of Therapeutics and Medical Consequences (DTMC)
3:30 p.m. NCCIH Director’s Address​
Dr. Helene Langevin, M.D., Director, National Center for Complementary and Integrative Health
4:15 p.m. Public Comments
4:30 p.m. Adjourn

This page was last updated August 2019